Garden Stage (GSIW) Cash & Equivalents (2023 - 2026)

Garden Stage has reported Cash & Equivalents for 4 years, with the latest figure at $17.5 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $17.5 million, up 122.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.5 million (up 122.19% YoY), and the FY2026 annual result was $17.5 million, up 122.19% from the prior year.
• Cash & Equivalents grew to $17.5 million in Q1 2026, from $7.9 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $17.5 million in Q1 2026 and troughed at $828689.0 in Q1 2023.
• A 4-year average of $7.4 million and a median of $7.9 million in 2025 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2024, when Cash & Equivalents surged 221.7%; it then soared 122.19% in 2026.
• A 4-year view of Cash & Equivalents shows it stood at $828689.0 in 2023, then surged by 861.77% to $8.0 million in 2024, then declined by 1.06% to $7.9 million in 2025, then soared by 122.19% to $17.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $17.5 million in Q1 2026, $7.9 million in Q1 2025, and $8.0 million in Q3 2024.